Potential role of platelet activating factor in acute renal failure

This publication has 62 references indexed in Scilit:

• THE PAF ANTAGONIST TCV-309 REDUCES GRAFT PMN INFILTRATION AND ENHANCES EARLY FUNCTION OF 24-HOUR-PRESERVED RAT KIDNEYS WITH LONG WARM ISCHEMIA
  Transplantation, 1996
• Prevention of cyclosporin nephrotoxicity with a platelet-activating factor (PAF) antagonist
  Nephrology Dialysis Transplantation, 1996
• Immune release of histamine and other lipid mediators from guinea-pig isolated kidney: Antagonism by BN-52021
  Inflammation Research, 1990
• EFFECT OF PLATELET-ACTIVATING FACTOR ANTAGONIST ON CYCLOSPORINE NEPHROTOXICITY
  Transplantation, 1989
• Increased levels of platelet-activating factor in blood following intestinal ischemia in the dog
  Biochemical and Biophysical Research Communications, 1989
• Paf-acether (platelet-activating factor) and interleukin-1-like cytokine production by lipopolysaccharide-stimulated glomeruli
  Clinical Immunology and Immunopathology, 1988
• The Role of Histamine H1 and H2 Receptors in the Canine Kidney
  Kidney and Blood Pressure Research, 1985
• Presence of platelet-activating factor in blood from humans and experimental animals. Its absence in anephric individuals
  Biochemical and Biophysical Research Communications, 1984
• Release of platelet-activating factor, slow-reacting substance, and vasoactive amines from isolated rat kidneys
  Kidney International, 1984
• Biosynthesis of 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine (platelet activating factor and a hypotensive lipid) by cholinephosphotransferase in various rat tissues
  Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1981